Skye Bioscience's total assets for Q1 2025 were $64.79B, an increase of 88946.01% from the previous quarter. SKYE total liabilities were $5.54B for the fiscal quarter, a 120083.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.